Not Yet Recruiting PHASE2 Interventional 2-arm
NCT03401164
Target Engagement of D-cycloserine (DCS)
Sponsor: NeuroRx, Inc.
Conditions
Major Depressive Disorder
Interventions
D-cycloserine Placebo
Updated 1 time since 2018 Last updated: Nov 27, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Major Depressive Disorder, this trial is actively recruiting participants. The trial is conducted by NeuroRx, Inc. and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- NeuroRx, Inc.
- New York State Psychiatric Institute
Data source: New York State Psychiatric Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.